Keywords: orphan, medical, sees, good, prospects, xyrem, firm

Orphan Medical sees good prospects for Xyrem

Article | 28 February 2005

Print This

US firm Orphan Medical's chief executive, John Bullion, believes his company'' lead product, Xyrem (sodium oxybate) for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in